Fluoxetine hydrochloride

CAS No. 56296-78-7

Fluoxetine hydrochloride( LY110140 )

Catalog No. M15048 CAS No. 56296-78-7

Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 43 In Stock
50MG 58 In Stock
100MG 74 In Stock
200MG 133 In Stock
500MG 227 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fluoxetine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
  • Description
    Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.(In Vitro):Fluoxetine hydrochloride (LY 110140) blocks the downregulation of cell proliferation resulting from inescapable shock (IS) of hippocampal cell. Fluoxetine increases the number of newborn cells in the dentate gyrus of the hippocampus of adult rat. Fluoxetine also increases the number of proliferating cells in the prelimbic cortex. Fluoxetine accelerates the maturation of immature neurons. Fluoxetine enhances neurogenesis-dependent long-term potentiation (LTP) in the dentate gyrus. Fluoxetine, but not citalopram, fluvoxamine, paroxetine and sertraline, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Fluoxetine produces robust and sustained increases in extracellular concentrations of norepinephrine and dopamine after acute systemic administration. (In Vivo):Fluoxetine hydrochloride (LY 110140) treatment also reverses the deficit in escape latency observed in animals exposed to inescapable shock in adult male Sprague-Dawley rats. Fluoxetine (5 mg/kg) alone increases cell proliferation in the dentate gyrus. Coadministration (fluoxetine 5 mg/kg + olanzapine) also significantly increases the number of BrdU-positive cells compared with the control group. Fluoxetine combined with Olanzapine produces robust, sustained increases of extracellular levels of dopamine ([DA](ex)) and norepinephrine ([NE](ex)) up to 361% and 272% of the baseline, respectively, which are significantly greater than either drug alone.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LY110140
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT| Sert (Sodium-dependent)
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    56296-78-7
  • Formula Weight
    345.79
  • Molecular Formula
    C17H18F3NO·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 69 mg/mL (199.54 mM); Water: 4 mg/mL (11.56 mM); DMSO: 69 mg/mL (199.54 mM)
  • SMILES
    Cl.CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Richman A, et al. Epilepsy Res. 2007 Apr;74(1):19-27.
molnova catalog
related products
  • Dexchlorpheniramine ...

    Dexchlorpheniramine (trade name Polaramine) is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.

  • 5-HT4 antagonist 1

    5-HT4 antagonist 1 is an antagonist of 5-HT4 (pKi = 9.6).

  • CID-25014542

    CID-25014542 is novel inhibitor of Raf kinases.